MILD COGNITIVE IMPAIRMENT TREATMENT SECRETS

For the reason that those who carry the APOE e4 gene variant appear to possess a higher risk of great complications, the FDA endorses being tested with the gene variant before beginning treatment with lecanemab or donanemab.Soon after being diagnosed with dementia, You will need to contemplate lots of specifics to get ready both you and your close